Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells - PubMed (original) (raw)
. 1992 Sep 9;52(2):252-60.
doi: 10.1002/ijc.2910520217.
Affiliations
- PMID: 1355757
- DOI: 10.1002/ijc.2910520217
Two new human cholangiocarcinoma cell lines and their cytogenetics and responses to growth factors, hormones, cytokines or immunologic effector cells
Y Shimizu et al. Int J Cancer. 1992.
Abstract
Two new human cholangiocarcinoma (CC) cell lines (CC-SW-I and CC-LP-I) were established and maintained in culture for 2 years. Histologically, both original liver tumors were adenocarcinomas, and the cell lines exhibited morphologic features of moderately differentiated adenocarcinoma. Immunohistochemistry showed that both cell lines were strongly positive for cytokeratin AEI but negative for carbohydrate tumor-associated antigen, CA19-9. Ultrastructural analysis of both cell lines showed the presence of tight junctional complexes and focally formed microvilli. Both CC cell lines were tumorigenic in nude mice. Cytogenetic analysis showed that both cell lines expressed highly aneuploid karyotypes with numerous structural and numerical deviations. CC-SW-I was hypodiploid with numerous chromosome losses and structural rearrangements, while CC-LP-I was hyperdiploid and displayed multiple additional chromosomes. Doubling times for the CC-SW-I and CC-LP-I cell lines in the presence of 15% fetal bovine serum were 72 hr and 180 hr, respectively. Growth of the CC-SW-I cell line was significantly stimulated in the presence of insulin, while that of the CC-LP-I cell line was significantly augmented by epidermal growth factor (EGF). In contrast, dexamethasone strongly inhibited proliferation of both cell lines in a dose-dependent manner. Among various recombinant cytokines examined for effects on growth or surface antigen expression on CC cell lines, only interleukin I-beta (ILI-beta) strongly inhibited growth of the CC-LP-I cell line, while interferons (IFNs) or tumor necrosis factor-alpha (TNF-alpha) were mildly inhibitory. Both tumor cell lines were resistant to natural killer (NK) cells but sensitive to lymphokine-activated killer (LAK) cells. Preincubation of tumor cells with IFN-gamma, IFN-alpha or TNF-alpha significantly decreased the susceptibility of each tumor cell line to lysis by LAK cells, and the change in sensitivity did not correlate with the expression of HLA antigens or intercellular adhesion molecule-I (ICAM-I) on the surface of tumor cells. These 2 CC cell lines are expected to provide valuable information about cell biology of human CC.
Similar articles
- Culture medium induced morphological changes of melanoma cells associated with change in sensitivity to lysis by lymphokine-activated killer cells.
Perng YP, Lin CC, Perng IM, Shen YC, Chuang CK, Liao SK. Perng YP, et al. Cancer Biother Radiopharm. 1997 Oct;12(5):317-31. doi: 10.1089/cbr.1997.12.317. Cancer Biother Radiopharm. 1997. PMID: 10851482 - [LAK sensitivity of human pancreas carcinoma cell lines].
Sugiura H. Sugiura H. Hokkaido Igaku Zasshi. 1993 Nov;68(6):921-34. Hokkaido Igaku Zasshi. 1993. PMID: 7906667 Japanese. - Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
Reiter Z. Reiter Z. Crit Rev Immunol. 1993;13(1):1-34. Crit Rev Immunol. 1993. PMID: 8466640 Review. - Interferon--a major regulator of natural killer cell-mediated cytotoxicity.
Reiter Z. Reiter Z. J Interferon Res. 1993 Aug;13(4):247-57. doi: 10.1089/jir.1993.13.247. J Interferon Res. 1993. PMID: 7693829 Review.
Cited by
- BRCA/Fanconi anemia pathway implicates chemoresistance to gemcitabine in biliary tract cancer.
Nakashima S, Kobayashi S, Nagano H, Tomokuni A, Tomimaru Y, Asaoka T, Hama N, Wada H, Kawamoto K, Marubashi S, Eguchi H, Doki Y, Mori M. Nakashima S, et al. Cancer Sci. 2015 May;106(5):584-91. doi: 10.1111/cas.12652. Epub 2015 Apr 22. Cancer Sci. 2015. PMID: 25736055 Free PMC article. - Development and Characterization of Human Primary Cholangiocarcinoma Cell Lines.
Isidan A, Yenigun A, Soma D, Aksu E, Lopez K, Park Y, Cross-Najafi A, Li P, Kundu D, House MG, Chakraborty S, Glaser S, Kennedy L, Francis H, Zhang W, Alpini G, Ekser B. Isidan A, et al. Am J Pathol. 2022 Sep;192(9):1200-1217. doi: 10.1016/j.ajpath.2022.05.007. Epub 2022 May 28. Am J Pathol. 2022. PMID: 35640676 Free PMC article. Review. - Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinoma.
Francis H, DeMorrow S, Venter J, Onori P, White M, Gaudio E, Francis T, Greene JF Jr, Tran S, Meininger CJ, Alpini G. Francis H, et al. Gut. 2012 May;61(5):753-64. doi: 10.1136/gutjnl-2011-300007. Epub 2011 Aug 26. Gut. 2012. PMID: 21873469 Free PMC article. - NEU overexpression in the furan rat model of cholangiocarcinogenesis compared with biliary ductal cell hyperplasia.
Sirica AE, Radaeva S, Caran N. Sirica AE, et al. Am J Pathol. 1997 Dec;151(6):1685-94. Am J Pathol. 1997. PMID: 9403719 Free PMC article. - Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker.
Goydos JS, Brumfield AM, Frezza E, Booth A, Lotze MT, Carty SE. Goydos JS, et al. Ann Surg. 1998 Mar;227(3):398-404. doi: 10.1097/00000658-199803000-00012. Ann Surg. 1998. PMID: 9527063 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials